120 related articles for article (PubMed ID: 23220069)
1. Lymphotoxin-beta receptor signalling regulates cytokine expression via TRIM30α in a TRAF3-dependent manner.
Wimmer N; Heigl U; Klingseisen L; Schneider-Brachert W; Hehlgans T
Mol Immunol; 2013 May; 54(1):40-7. PubMed ID: 23220069
[TBL] [Abstract][Full Text] [Related]
2. Lymphotoxin β receptor activation on macrophages induces cross-tolerance to TLR4 and TLR9 ligands.
Wimmer N; Huber B; Barabas N; Röhrl J; Pfeffer K; Hehlgans T
J Immunol; 2012 Apr; 188(7):3426-33. PubMed ID: 22357629
[TBL] [Abstract][Full Text] [Related]
3. Lymphotoxin-beta receptor activation on macrophages ameliorates acute DSS-induced intestinal inflammation in a TRIM30α-dependent manner.
Wimmer N; Huber B; Wege AK; Barabas N; Röhrl J; Pfeffer K; Hehlgans T
Mol Immunol; 2012 Jun; 51(2):128-35. PubMed ID: 22437076
[TBL] [Abstract][Full Text] [Related]
4. Blocking lymphotoxin beta receptor signalling exacerbates acute DSS-induced intestinal inflammation--opposite functions for surface lymphotoxin expressed by T and B lymphocytes.
Jungbeck M; Stopfer P; Bataille F; Nedospasov SA; Männel DN; Hehlgans T
Mol Immunol; 2008 Jan; 45(1):34-41. PubMed ID: 17590442
[TBL] [Abstract][Full Text] [Related]
5. Lymphotoxin-β receptor activation by lymphotoxin-α(1)β(2) and LIGHT promotes tumor growth in an NFκB-dependent manner.
Daller B; Müsch W; Röhrl J; Tumanov AV; Nedospasov SA; Männel DN; Schneider-Brachert W; Hehlgans T
Int J Cancer; 2011 Mar; 128(6):1363-70. PubMed ID: 20473944
[TBL] [Abstract][Full Text] [Related]
6. Activation of lymphotoxin-beta receptor enhances the LPS-induced expression of IL-8 through NF-κB and IRF-1.
Jang SW; Lim SG; Suk K; Lee WH
Immunol Lett; 2015 Jun; 165(2):63-9. PubMed ID: 25887375
[TBL] [Abstract][Full Text] [Related]
7. Lymphotoxin β receptor activation promotes mRNA expression of RelA and pro-inflammatory cytokines TNFα and IL-1β in bladder cancer cells.
Shen M; Zhou L; Zhou P; Zhou W; Lin X
Mol Med Rep; 2017 Jul; 16(1):937-942. PubMed ID: 28586003
[TBL] [Abstract][Full Text] [Related]
8. The MYND domain-containing protein BRAM1 inhibits lymphotoxin beta receptor-mediated signaling through affecting receptor oligomerization.
Liu HP; Chung PJ; Liang CL; Chang YS
Cell Signal; 2011 Jan; 23(1):80-8. PubMed ID: 20732415
[TBL] [Abstract][Full Text] [Related]
9. M1 macrophages act as LTβR-independent lymphoid tissue inducer cells during atherosclerosis-related lymphoid neogenesis.
Guedj K; Khallou-Laschet J; Clement M; Morvan M; Gaston AT; Fornasa G; Dai J; Gervais-Taurel M; Eberl G; Michel JB; Caligiuri G; Nicoletti A
Cardiovasc Res; 2014 Mar; 101(3):434-43. PubMed ID: 24272771
[TBL] [Abstract][Full Text] [Related]
10. Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.
Xu H; An H; Hou J; Han C; Wang P; Yu Y; Cao X
Mol Immunol; 2008 Aug; 45(13):3545-52. PubMed ID: 18571728
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of lymphotoxin-beta receptor-mediated cell death by survivin-DeltaEx3.
You RI; Chen MC; Wang HW; Chou YC; Lin CH; Hsieh SL
Cancer Res; 2006 Mar; 66(6):3051-61. PubMed ID: 16540654
[TBL] [Abstract][Full Text] [Related]
12. Lymphotoxin-alpha 1 beta 2 and LIGHT induce classical and noncanonical NF-kappa B-dependent proinflammatory gene expression in vascular endothelial cells.
Madge LA; Kluger MS; Orange JS; May MJ
J Immunol; 2008 Mar; 180(5):3467-77. PubMed ID: 18292573
[TBL] [Abstract][Full Text] [Related]
13. Lymphotoxin-beta receptor signaling regulates hepatic stellate cell function and wound healing in a murine model of chronic liver injury.
Ruddell RG; Knight B; Tirnitz-Parker JE; Akhurst B; Summerville L; Subramaniam VN; Olynyk JK; Ramm GA
Hepatology; 2009 Jan; 49(1):227-39. PubMed ID: 19111021
[TBL] [Abstract][Full Text] [Related]
14. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6.
Häcker H; Redecke V; Blagoev B; Kratchmarova I; Hsu LC; Wang GG; Kamps MP; Raz E; Wagner H; Häcker G; Mann M; Karin M
Nature; 2006 Jan; 439(7073):204-7. PubMed ID: 16306937
[TBL] [Abstract][Full Text] [Related]
15. Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation.
Radtke S; Wüller S; Yang XP; Lippok BE; Mütze B; Mais C; de Leur HS; Bode JG; Gaestel M; Heinrich PC; Behrmann I; Schaper F; Hermanns HM
J Cell Sci; 2010 Mar; 123(Pt 6):947-59. PubMed ID: 20200229
[TBL] [Abstract][Full Text] [Related]
16. Activation of the lymphotoxin-beta receptor induces NFkappaB-dependent interleukin-6 and MIP-2 secretion in mouse fibrosarcoma cells.
Hehlgans T; Müller P; Stopfer P; Männel DN
Eur Cytokine Netw; 2003; 14(2):103-7. PubMed ID: 12957791
[TBL] [Abstract][Full Text] [Related]
17. Lymphotoxin-beta receptor activation by activated T cells induces cytokine release from mouse bone marrow-derived mast cells.
Stopfer P; Männel DN; Hehlgans T
J Immunol; 2004 Jun; 172(12):7459-65. PubMed ID: 15187124
[TBL] [Abstract][Full Text] [Related]
18. The lymphotoxin β receptor is a potential therapeutic target in renal inflammation.
Seleznik G; Seeger H; Bauer J; Fu K; Czerkowicz J; Papandile A; Poreci U; Rabah D; Ranger A; Cohen CD; Lindenmeyer M; Chen J; Edenhofer I; Anders HJ; Lech M; Wüthrich RP; Ruddle NH; Moeller MJ; Kozakowski N; Regele H; Browning JL; Heikenwalder M; Segerer S
Kidney Int; 2016 Jan; 89(1):113-26. PubMed ID: 26398497
[TBL] [Abstract][Full Text] [Related]
19. Modulation of cytokine gene expression by cathelicidin BMAP-28 in LPS-stimulated and -unstimulated macrophages.
D'Este F; Tomasinsig L; Skerlavaj B; Zanetti M
Immunobiology; 2012 Oct; 217(10):962-71. PubMed ID: 22317752
[TBL] [Abstract][Full Text] [Related]
20. Beta-defensins activate macrophages and synergize in pro-inflammatory cytokine expression induced by TLR ligands.
Barabas N; Röhrl J; Holler E; Hehlgans T
Immunobiology; 2013 Jul; 218(7):1005-11. PubMed ID: 23332217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
